(Q51126863)

30 March 2018

title

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice. (English)

1 reference

30 March 2018

1 reference

R J Rodgers

1

1 reference

30 March 2018

J C Cole

series ordinal

2

1 reference

30 March 2018

J M Tredwell

series ordinal

3

1 reference

30 March 2018

publication date

1 February 1995

1 reference

30 March 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

30 March 2018

volume

117

1 reference

30 March 2018

page(s)

306-312

1 reference

30 March 2018

issue

3

1 reference

30 March 2018

https://scigraph.springernature.com/pub.10.1007/bf02246105

exact match

0 references

cites work

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246105

Anxiolytic profile of GR 38032F in the potentiated startle paradigm

21 January 2018

1 reference

12 December 2020

A proposed new nomenclature for 5-HT receptors.

1 reference

12 December 2020

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

1 reference

12 December 2020

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

1 reference

12 December 2020

5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions

1 reference

12 December 2020

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

12 December 2020

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

12 December 2020

Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Ondansetron, gender and antipredator defensive behaviour

1 reference

12 December 2020

A step in the right direction: comment on '5-HT and mechanisms of defence'

1 reference

12 December 2020

The characterization and modelling of antipredator defensive behavior

1 reference

12 December 2020

Anxiogenic stimuli in the elevated plus-maze.

1 reference

12 December 2020

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

12 December 2020

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

12 December 2020

Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP.

1 reference

12 December 2020

Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice.

1 reference

12 December 2020

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

12 December 2020

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties

1 reference

12 December 2020

Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage

1 reference

12 December 2020

Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.

1 reference

12 December 2020

Anxiolytic potential of 5-HT3 receptor antagonists

1 reference

12 December 2020

The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.

1 reference

12 December 2020

The 5-HT3 receptor antagonists ICS 205-930 and GR38032F, putative anxiolytic drugs, differ from diazepam in their pharmacological profile

1 reference

12 December 2020

The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety.

1 reference

12 December 2020

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

12 December 2020

Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.

1 reference

12 December 2020

Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.

1 reference

12 December 2020

Centrally active 5-HT receptor agonists and antagonists

1 reference

12 December 2020

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

1 reference

12 December 2020

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

12 December 2020

Buspirone and related compounds as alternative anxiolytics

1 reference

12 December 2020

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.

1 reference

12 December 2020

Serotonin mechanisms in animal models of anxiety.

1 reference

12 December 2020

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential

1 reference

12 December 2020

Resistance of baseline activity in the elevated plus-maze to exogenous influences.

1 reference

12 December 2020

Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246105

1 reference

30 March 2018

PubMed ID

7770606

1 reference

30 March 2018